These histories from Brent, somuchmore2, and others about a decision not to treat followed by more-or-less rapid progression are frightening. I'm going to translate them into Spanish and force my hep MD to listen and give me a reply, the next time I see him. I'm very concerned that he and the other hepatologists here in Buenos Aires are judging things by old, bad information.
Re biopsies, I've read a lot of articles that say they can't be trusted. It's not just that different people with different experience are analyzing the biopsy samples, but the very nature of a biopsy - a very small specimen of the liver - makes it untrustworthy. An article in the February issue of Hepatology on a new test, FibroTC, is especially interesting for the light it throws on this point, in regard to the often non-homogeneous nature of liver fibrosis, which makes biopsies appear seriously unreliable. Here's the URL: http://www.ncbi.nlm.nih.gov/pubmed/18098299?dopt=Abstract
By the way, got a copy of that article from the authors andI posted an image from it on my forum webpage, if anyone wants to look at it. It's the multi-colored graph. Click on it to make it bigger (or just go to
http://www.medhelp.org/user_photos/show/8507). The image shows a FibroTC analysis of an HCV-infected liver that has four different stages of fibrosis in it. What good would a biopsy be on that person's liver? Depending on where the needle went in, anything from F2 to F4 could be diagnosed.
Re upbeat's post, I believe there is evidence that treating HCV runs the risk of powering up the virus if it isn't eliminated. It's the old "what doesn't kill you makes you stronger" idea, and it's as true for microbes as it is for humans, I believe. It's always dangerous to treat and not cure. That's why they tell you not to stop taking antibiotics before finishing the box, even if the infection you're taking them for has cleared up.
I don't really know how interferon and ribavirin work, on a molecular level, but the suppression of viral genotype breakouts is not the only concern. There's the problem of the drugs pushing the present genotype into a more virulent mode. Viruses have different virulences (power to cause cellular harm) just like bacteria do. Normally a microbe doesn't evolve a higher virulence than infection/transmission allows, on the principle that if it is so virulent that it kills its victim before he or she transmits the infection then it dies off with the victim. But taking drugs can alter that equilibrium. And the evolution of HCV is super fast. It has a huge reproduction rate.
I think a lot of interesting discussion has come out of this thread and the forum in general on these questions, particularly the treat/wait thing. It's too bad there isn't more being done by research to solve them, like coming up with a really good non-invasive liver damage test. As long as the medical community sticks to their age-old biopsy belief, we aren't going to make much progress.
Mike